ATLASAnika Therapeutics (ANIK) earnings date: Nov 6, 2026
Anika Therapeutics (ANIK) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026, before the open. Analysts expect EPS of $0.02.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ANIK
| Last price | $19.40 (-7.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Anika Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Anika Therapeutics reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Anika Therapeutics. You can switch it off at any time.
Alert me before ANIK reportsFree to start. Creating an account takes under a minute.
Notify me when Anika Therapeutics reports
Track ANIK free Add Anika Therapeutics to a free ATLAS watchlist and see its next report date in one place.
ANIK earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.02 |
| Last report | Jul 29, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +709.9% |
| Average move around a report | ±13.5% (last 4) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Anika Therapeutics earnings history: last 4 reports
Anika Therapeutics last reported on Jul 29, 2026: EPS of $0.42 against an estimate of $0.03 (+1,300.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 29, 2026 | $0.03 | $0.42 | +1,300.0% | Beat | +19.3% |
| Feb 26, 2026 | $0.02 | $0.31 | +1,450.0% | Beat | +31.3% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | +2.3% |
| Nov 5, 2025 | $0.02 | $0.04 | +100.0% | Beat | +1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ANIK
See the fair value, the probability range and the earnings history of Anika Therapeutics on its ATLAS page.
Anika Therapeutics (ANIK) stock analysisPlans from €3.99 a month.
Anika Therapeutics earnings: frequently asked questions
When does Anika Therapeutics (ANIK) report earnings?
Anika Therapeutics is scheduled to report on Friday, November 6, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ANIK?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.02 per share (USD). Estimates can change before the report.
How often does ANIK beat earnings estimates?
Of its last 4 reports with a recorded result, Anika Therapeutics beat the EPS estimate 3 times; the average surprise was +709.9%. Past results do not predict the next one.
How much does ANIK move around earnings?
Over its last 4 reports the stock moved an average of 13.5% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Anika Therapeutics beat earnings estimates last quarter?
Anika Therapeutics last reported on Jul 29, 2026: EPS of $0.42 against an estimate of $0.03 (+1,300.0% surprise), a beat.
How much does ANIK usually move in a day?
On a normal trading day the ATLAS model puts ANIK’s one-day range at about ±2.6%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer